NCT00872495 Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
| NCT ID | NCT00872495 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lahey Clinic |
| Condition | Urothelial Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2002-09 |
| Primary Completion | 2028-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2002-09 with a primary completion date of 2028-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence
Eligibility Criteria
Inclusion Criteria: * Patients scheduled to have a nephroureterectomy, cystectomy, cytoscopy (newly diagnosed bladder cancer and those with recurrent disease in follow up) * Control Group: No known evidence of bladder cancer-one urine sample * \> than 18 years of age Exclusion Criteria: * \< than 18 years of age
Contact & Investigator
Kimberly Rieger-Christ, PhD
PRINCIPAL INVESTIGATOR
Lahey Clinic, Inc.
Frequently Asked Questions
Who can join the NCT00872495 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Urothelial Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00872495 currently recruiting?
Yes, NCT00872495 is actively recruiting participants. Contact the research team at Kimberly.R.Christ@lahey.org for enrollment information.
Where is the NCT00872495 trial being conducted?
This trial is being conducted at Burlington, United States.
Who is sponsoring the NCT00872495 clinical trial?
NCT00872495 is sponsored by Lahey Clinic. The principal investigator is Kimberly Rieger-Christ, PhD at Lahey Clinic, Inc.. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.